KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Acquisitions & Divestments (2017 - 2025)

Historic Change in Acquisitions & Divestments for Opko Health (OPK) over the last 10 years, with Q1 2025 value amounting to $51.7 million.

  • Opko Health's Change in Acquisitions & Divestments changed N/A to $51.7 million in Q1 2025 from the same period last year, while for Sep 2025 it was $171.5 million, marking a year-over-year increase of 26705.4%. This contributed to the annual value of $166.6 million for FY2024, which is 4567032.97% up from last year.
  • Opko Health's Change in Acquisitions & Divestments amounted to $51.7 million in Q1 2025.
  • Opko Health's 5-year Change in Acquisitions & Divestments high stood at $119.9 million for Q4 2024, and its period low was -$478000.0 during Q3 2023.
  • In the last 5 years, Opko Health's Change in Acquisitions & Divestments had a median value of $27.4 million in 2021 and averaged $42.8 million.
  • The largest annual percentage gain for Opko Health's Change in Acquisitions & Divestments in the last 5 years was 987635.98% (2024), contrasted with its biggest fall of 987635.98% (2024).
  • Over the past 5 years, Opko Health's Change in Acquisitions & Divestments (Quarter) stood at $8.1 million in 2021, then surged by 1328.68% to $115.4 million in 2022, then crashed by 100.41% to -$478000.0 in 2023, then soared by 25178.03% to $119.9 million in 2024, then plummeted by 56.91% to $51.7 million in 2025.
  • Its last three reported values are $51.7 million in Q1 2025, $119.9 million for Q4 2024, and $46.7 million during Q3 2024.